Literature DB >> 2085486

Analysis of recent thymic emigrants with subset- and maturity-related markers.

K A Kelly1, R Scollay.   

Abstract

The thymus plays an integral role in the development and production of T lymphocytes. However, thymocytes differ markedly in their phenotypic characteristics from the T cells normally found in the peripheral lymphoid organs. We have examined the phenotypic characteristics of recent thymic emigrants and compared them with both mature phenotype thymocytes (CD4+ CD8-CD3+ and CD4-CD8+ CD3+) and lymph node T cells. Recent thymic emigrants were defined as those fluorescein-positive cells found in the lymph node up to 16 h after intrathymic injection of fluorescein. Most cells emigrating from the thymus expressed CD3 and either CD4 or CD8, indicating maturity. Recent thymic emigrants, like mature phenotype thymocytes, were slightly larger on average than peripheral T cells, but this differential was lost within 24 h of emigration. Also like mature thymocytes but unlike peripheral T cells, some recent emigrants expressed heat-stable antigen. This did not change within 24 h of emigration. The antigen CD44 (Pgp-1, Ly-24) was expressed on a proportion of mature thymocytes, recent thymic emigrants, and peripheral T cells, and its expression did not show any clear relationship to maturity. The antigen CD45R also did not show marked changes associated with maturity, but our data do not parallel the published data of the expression of CD45R in the human. We conclude that recent thymic emigrants are phenotypically mature with respect to some antigens but not others. None of the antigens we investigated could have been used to uniquely distinguish recent thymic emigrants from peripheral T cells or from mature thymocytes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2085486     DOI: 10.1093/intimm/2.5.419

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  25 in total

1.  Activation of Fas by FasL induces apoptosis by a mechanism that cannot be blocked by Bcl-2 or Bcl-x(L).

Authors:  D C Huang; M Hahne; M Schroeter; K Frei; A Fontana; A Villunger; K Newton; J Tschopp; A Strasser
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

2.  Recent thymic emigrants are biased against the T-helper type 1 and toward the T-helper type 2 effector lineage.

Authors:  Deborah W Hendricks; Pamela J Fink
Journal:  Blood       Date:  2010-11-03       Impact factor: 22.113

3.  Thymocyte development is normal in CTLA-4-deficient mice.

Authors:  C A Chambers; D Cado; T Truong; J P Allison
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

4.  Naive and innate memory phenotype CD4+ T cells have different requirements for active Itk for their development.

Authors:  Jianfang Hu; Avery August
Journal:  J Immunol       Date:  2008-05-15       Impact factor: 5.422

5.  Naive T cells proliferate strongly in neonatal mice in response to self-peptide/self-MHC complexes.

Authors:  Armelle Le Campion; Christine Bourgeois; Florence Lambolez; Bruno Martin; Sandrine Léaument; Nicole Dautigny; Corinne Tanchot; Claude Pénit; Bruno Lucas
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-26       Impact factor: 11.205

Review 6.  Reinterpreting recent thymic emigrant function: defective or adaptive?

Authors:  Cody A Cunningham; Eric Y Helm; Pamela J Fink
Journal:  Curr Opin Immunol       Date:  2017-12-16       Impact factor: 7.486

Review 7.  Lifespan of lymphocytes.

Authors:  D F Tough; J Sprent
Journal:  Immunol Res       Date:  1995       Impact factor: 2.829

8.  The survival and turnover of mature and immature CD8 T cells.

Authors:  M McDonagh; E B Bell
Journal:  Immunology       Date:  1995-04       Impact factor: 7.397

9.  BB-DR/Edinburgh: a lymphopenic, non-diabetic subline of BB rats.

Authors:  S Joseph; A G Diamond; W Smith; J D Baird; G W Butcher
Journal:  Immunology       Date:  1993-02       Impact factor: 7.397

10.  Emigration of mature T cells from the thymus is inhibited by the imidazole-based compound 2-acetyl-4-tetrahydroxybutylimidazole.

Authors:  R Gugasyan; A Coward; L O'Connor; K Shortman; R Scollay
Journal:  Immunology       Date:  1998-03       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.